1. Home
  2. ALLO vs NNDM Comparison

ALLO vs NNDM Comparison

Compare ALLO & NNDM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALLO
  • NNDM
  • Stock Information
  • Founded
  • ALLO 2017
  • NNDM 2012
  • Country
  • ALLO United States
  • NNDM United States
  • Employees
  • ALLO N/A
  • NNDM N/A
  • Industry
  • ALLO Biotechnology: Biological Products (No Diagnostic Substances)
  • NNDM Electrical Products
  • Sector
  • ALLO Health Care
  • NNDM Technology
  • Exchange
  • ALLO Nasdaq
  • NNDM Nasdaq
  • Market Cap
  • ALLO 363.1M
  • NNDM 334.6M
  • IPO Year
  • ALLO 2018
  • NNDM N/A
  • Fundamental
  • Price
  • ALLO $1.40
  • NNDM $1.40
  • Analyst Decision
  • ALLO Strong Buy
  • NNDM
  • Analyst Count
  • ALLO 9
  • NNDM 0
  • Target Price
  • ALLO $8.44
  • NNDM N/A
  • AVG Volume (30 Days)
  • ALLO 3.5M
  • NNDM 2.6M
  • Earning Date
  • ALLO 08-06-2025
  • NNDM 08-19-2025
  • Dividend Yield
  • ALLO N/A
  • NNDM N/A
  • EPS Growth
  • ALLO N/A
  • NNDM N/A
  • EPS
  • ALLO N/A
  • NNDM N/A
  • Revenue
  • ALLO N/A
  • NNDM $58,812,000.00
  • Revenue This Year
  • ALLO N/A
  • NNDM N/A
  • Revenue Next Year
  • ALLO $199.63
  • NNDM N/A
  • P/E Ratio
  • ALLO N/A
  • NNDM N/A
  • Revenue Growth
  • ALLO N/A
  • NNDM 7.49
  • 52 Week Low
  • ALLO $0.86
  • NNDM $1.34
  • 52 Week High
  • ALLO $3.78
  • NNDM $2.74
  • Technical
  • Relative Strength Index (RSI)
  • ALLO 54.41
  • NNDM 34.59
  • Support Level
  • ALLO $1.21
  • NNDM $1.47
  • Resistance Level
  • ALLO $1.31
  • NNDM $1.59
  • Average True Range (ATR)
  • ALLO 0.11
  • NNDM 0.06
  • MACD
  • ALLO 0.02
  • NNDM -0.01
  • Stochastic Oscillator
  • ALLO 40.82
  • NNDM 10.71

About ALLO Allogene Therapeutics Inc.

Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-cell candidates designed to target cancer cells or autoreactive cells in autoimmune disorders. Notably, their allogeneic approach, derived from healthy donors, allows for broader patient eligibility and scalability. With a vision to redefine CAR T therapy, the company concentrates on core programs targeting lymphoma, leukemia, autoimmune diseases, and solid tumors. Revenue, generated from collaborations and licensing agreements, supports their research and development efforts.

About NNDM Nano Dimension Ltd.

Nano Dimension Ltd provide industrial manufacturing solutions for design-to-manufacturing of electronics and mechanical parts. These solutions are based on a combination of hardware, software, and materials science technologies. The solutions include industrial machinery, such as those for additive manufacturing, surface-mount technology, industrial inkjet printing, along with software for design, simulation, and manufacturing management, as well as materials or consumables that are used by the machinery. These solutions are used by industrial customers in aerospace & defense, automotive, electronics, medical, research and academia, along with government organizations.

Share on Social Networks: